Jane Hennings

Title: Innovations by Jane Hennings in the Field of Veterinary Science

Introduction

Jane Hennings is an accomplished inventor based in Arlington, South Dakota. She has made significant contributions to the field of veterinary science, particularly in addressing challenges faced by the pork industry. Her innovative work focuses on the development of vaccines that can differentiate between vaccinated animals and those naturally infected with the virus.

Latest Patents

Jane Hennings holds a patent for her invention titled "Recombinant North American type 1 porcine reproductive and respiratory syndrome virus and methods of use." This invention addresses the major problem of Porcine reproductive and respiratory syndrome virus (PRRSV) in the pork industry worldwide. The inclusion of markers in vaccines allows for diagnostic differentiation of vaccinated animals from those naturally infected with the wild-type virus. Using a cDNA infectious clone of North American Type 1 PRRSV, she has developed a recombinant green fluorescent protein (GFP) tagged PRRSV, which contains a deletion of an immunogenic epitope, ES4, in the nsp2 region. The GFP and ES4 epitope-based ELISAs complement the marker identification.

Career Highlights

Jane Hennings is affiliated with South Dakota State University, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and management of PRRSV, which is a significant concern for pork producers.

Collaborations

Jane has collaborated with notable colleagues, including Ying Fang and Eric A Nelson, to further her research initiatives and enhance the impact of her inventions.

Conclusion

Jane Hennings is a pioneering inventor whose work in developing innovative solutions for the pork industry has the potential to transform veterinary practices. Her contributions are vital in addressing the challenges posed by PRRSV, ensuring better health outcomes for livestock.